Catalysts for ViiV Healthcare Company
93 tracked
Mar 30, 2022
approval
TRIUMEQ (ABACAVIR SULFATE) — FDA approval
ViiV Healthcare Company
→
Mar 29, 2022
approval
CABENUVA KIT (CABOTEGRAVIR) — FDA approval
ViiV Healthcare Company
→
Mar 29, 2022
approval
CABENUVA KIT (CABOTEGRAVIR) — FDA approval
ViiV Healthcare Company
→
Mar 23, 2022
approval
CABENUVA KIT (CABOTEGRAVIR) — FDA approval
ViiV Healthcare Company
→
Feb 7, 2022
approval
CABENUVA KIT (CABOTEGRAVIR) — FDA approval
ViiV Healthcare Company
→
Jan 31, 2022
approval
CABENUVA KIT (CABOTEGRAVIR) — FDA approval
ViiV Healthcare Company
→
Jan 20, 2022
approval
DOVATO (DOLUTEGRAVIR SODIUM) — FDA approval
ViiV Healthcare Company
→
Jan 20, 2022
approval
DOVATO (DOLUTEGRAVIR SODIUM) — FDA approval
ViiV Healthcare Company
→
Jul 9, 2021
approval
JULUCA (DOLUTEGRAVIR SODIUM) — FDA approval
ViiV Healthcare Company
→
Jul 9, 2021
approval
TIVICAY PD (DOLUTEGRAVIR SODIUM) — FDA approval
ViiV Healthcare Company
→
Jul 9, 2021
approval
TIVICAY (DOLUTEGRAVIR SODIUM) — FDA approval
ViiV Healthcare Company
→
Mar 23, 2021
approval
DOVATO (DOLUTEGRAVIR SODIUM) — FDA approval
ViiV Healthcare Company
→
Mar 23, 2021
approval
JULUCA (DOLUTEGRAVIR SODIUM) — FDA approval
ViiV Healthcare Company
→
Mar 23, 2021
approval
TIVICAY PD (DOLUTEGRAVIR SODIUM) — FDA approval
ViiV Healthcare Company
→
Mar 23, 2021
approval
TIVICAY (DOLUTEGRAVIR SODIUM) — FDA approval
ViiV Healthcare Company
→
Mar 23, 2021
approval
TRIUMEQ (ABACAVIR SULFATE) — FDA approval
ViiV Healthcare Company
→
Mar 1, 2021
approval
DOVATO (DOLUTEGRAVIR SODIUM) — FDA approval
ViiV Healthcare Company
→
Mar 1, 2021
approval
TRIUMEQ (ABACAVIR SULFATE) — FDA approval
ViiV Healthcare Company
→
Jan 21, 2021
approval
CABENUVA KIT (CABOTEGRAVIR) — FDA approval
ViiV Healthcare Company
→
Aug 6, 2020
approval
DOVATO (DOLUTEGRAVIR SODIUM) — FDA approval
ViiV Healthcare Company
→
Aug 6, 2020
approval
DOVATO (DOLUTEGRAVIR SODIUM) — FDA approval
ViiV Healthcare Company
→
Jul 14, 2020
approval
JULUCA (DOLUTEGRAVIR SODIUM) — FDA approval
ViiV Healthcare Company
→
Jun 12, 2020
approval
TIVICAY PD (DOLUTEGRAVIR SODIUM) — FDA approval
ViiV Healthcare Company
→
Jun 12, 2020
approval
TIVICAY (DOLUTEGRAVIR SODIUM) — FDA approval
ViiV Healthcare Company
→
Mar 24, 2020
approval
DOVATO (DOLUTEGRAVIR SODIUM) — FDA approval
ViiV Healthcare Company
→
Mar 24, 2020
approval
TIVICAY (DOLUTEGRAVIR SODIUM) — FDA approval
ViiV Healthcare Company
→
Mar 24, 2020
approval
TRIUMEQ (ABACAVIR SULFATE) — FDA approval
ViiV Healthcare Company
→
Oct 24, 2019
approval
DOVATO (DOLUTEGRAVIR SODIUM) — FDA approval
ViiV Healthcare Company
→
Oct 24, 2019
approval
JULUCA (DOLUTEGRAVIR SODIUM) — FDA approval
ViiV Healthcare Company
→
Oct 24, 2019
approval
TIVICAY (DOLUTEGRAVIR SODIUM) — FDA approval
ViiV Healthcare Company
→